Colin Walsh - 24 Jun 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Shawn Leland, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
4
Filing time
28 Jun 2021, 18:21:14 UTC
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Director Stock Option (Right to Buy) Award $0 +31,238 $0.000000 31,238 24 Jun 2021 Common Stock 31,238 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/36 of the total shares monthly beginning on July 24, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.